Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M.
Aragó M, Moreno-Felici J, Abás S, Rodríguez-Arévalo S, Hyroššová P, Figueras A, Viñals F, Pérez B, Loza MI, Brea J, Latorre P, Carrodeguas JA, García-Rovés PM, Galdeano C, Ginex T, Luque FJ, Escolano C, Perales JC.
Aragó M, et al. Among authors: latorre p.
Biomed Pharmacother. 2020 Jan;121:109601. doi: 10.1016/j.biopha.2019.109601. Epub 2019 Nov 15.
Biomed Pharmacother. 2020.
PMID: 31739159
Free article.